Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations


Diabetic nephropathy is a major complication of diabetes mellitus and the leading cause of end-stage renal disease. Both hyperglycemia and hypertension (systemic and/or intraglomerular) are established causal factors for diabetic nephropathy. Nonetheless, there is growing evidence that activated innate immunity and inflammation are also contributing factors to the pathogenesis of diabetic nephropathy. This notion is based on increasing evidence indicating that both cytokines-chemokines and pro-fibrotic growth factors are important players in the progression of diabetic nephropathy, effectively accelerating and exacerbating inflammatory and fibrotic processes leading to endstage renal disease. In this review, we focus on several predominant cytokines-chemokines as potential predictive markers for diabetic nephropathy. These cytokineschemokines may also be helpful as biomarkers to monitor the progression of the disease and the impact of interventional modalities aimed at halting eventual manifestation of end-stage renal disease in diabetic patients.

Original languageEnglish (US)
Pages (from-to)117-129
Number of pages13
JournalEPMA Journal
Issue number1
StatePublished - Mar 2010


  • Advanced predictive diagnostics
  • Cytokines/chemokines
  • Disease monitoring
  • Major complication of diabetes
  • Personalized patient treatment
  • Renal disease

ASJC Scopus subject areas

  • Drug Discovery
  • Health Policy
  • Biochemistry, medical


Dive into the research topics of 'Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy'. Together they form a unique fingerprint.

Cite this